Status:
ENROLLING_BY_INVITATION
Self- Sampling in Cervical Cancer Routine Screening
Lead Sponsor:
Tampere University Hospital
Conditions:
Cervical Cancer Screening
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
SELF-SAMPLING IN CERVICAL CANCER ROUTINE SCREENING (FALCON) -Study implements a self-sampling option for the non-attendees of the national cervical cancer screening program in the Wellbeing Services C...
Eligibility Criteria
Inclusion
- Women that do not respond to the first national cervical cancer screening invitation in 2024 and 2025 and to whom the reminder letter is sent to.
- Birth cohorts of women who will turn in screening year: 30, 35, 40, 45, 50, 55, 60 or 65 years old.
Exclusion
- Women who do not belong to the screening year 2024 or 2025 invitation birth cohorts.
Key Trial Info
Start Date :
June 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT06931184
Start Date
June 11 2024
End Date
December 31 2029
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital and Tampere University
Tampere, Pirkanmaa, Finland, 33520